Pam-YDL

ID: ALA210871

Chembl Id: CHEMBL210871

PubChem CID: 15605028

Max Phase: Preclinical

Molecular Formula: C35H57N3O8

Molecular Weight: 647.85

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCCCCCCCCCCCCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O

Standard InChI:  InChI=1S/C35H57N3O8/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-31(40)36-28(23-26-18-20-27(39)21-19-26)33(43)37-29(24-32(41)42)34(44)38-30(35(45)46)22-25(2)3/h18-21,25,28-30,39H,4-17,22-24H2,1-3H3,(H,36,40)(H,37,43)(H,38,44)(H,41,42)(H,45,46)/t28-,29-,30-/m0/s1

Standard InChI Key:  HZVNKGUULBQQTM-DTXPUJKBSA-N

Alternative Forms

  1. Parent:

    ALA210871

    Pam-YDL

Associated Targets(non-human)

PRE2 Proteasome Macropain subunit PRE2 (43 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PRE1 Proteasome Macropain subunit (35 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PRE7 Proteasome component C5 (37 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 647.85Molecular Weight (Monoisotopic): 647.4146AlogP: 5.48#Rotatable Bonds: 26
Polar Surface Area: 182.13Molecular Species: ACIDHBA: 6HBD: 6
#RO5 Violations: 3HBA (Lipinski): 11HBD (Lipinski): 6#RO5 Violations (Lipinski): 4
CX Acidic pKa: 3.58CX Basic pKa: CX LogP: 6.61CX LogD: 0.26
Aromatic Rings: 1Heavy Atoms: 46QED Weighted: 0.07Np Likeness Score: 0.26

References

1. Basse N, Papapostolou D, Pagano M, Reboud-Ravaux M, Bernard E, Felten AS, Vanderesse R..  (2006)  Development of lipopeptides for inhibiting 20S proteasomes.,  16  (12): [PMID:16630721] [10.1016/j.bmcl.2006.03.033]

Source